Investor Alert: Complaint Filed Against Steve Hlibok — May Recover Losses
Stephen Charles Newell Hlibok (also known as Stephen Hlibok or Steve Hlibok; CRD #1728900) is currently registered with Merrill Lynch, Pierce, Fenner & Smith Incorporated. Customers should be aware of the pending complaint filed against Steve Hlibok.
According to his FINRA BrokerCheck report, a customer complaint filed on September 29, 2025 alleges unauthorized trading in OTC equities. The client is claiming damages of $337,668.75.
If you invested with Stephen Hlibok—especially in OTC stocks or other high-volatility securities—review your account statements, trade confirmations, and adviser communications to determine whether trades were executed with your consent and were suitable for your risk profile.
If you believe the situation parallels the allegation, you may have grounds to seek recovery of losses through FINRA arbitration or other legal options.
Investor Alert: Complaint Filed Against Steve Hlibok — May Recover Losses
Goodman & Nekvasil, P.A., is investigating brokers who may have unsuitably recommended investments to their clients.
St. Petersburg, Florida law firm Goodman & Nekvasil, P.A., has a national practice representing victimized investors. The firm continues to investigate brokerage firms that placed elderly retirees and other conservative investors in unsuitable investments.
Goodman & Nekvasil, P.A., has filed numerous cases against brokerage firms selling high-risk investments and has recovered more than $500 million dollars on behalf of victimized investors.
We allege in these cases that these investment recommendations were unsuitable for our clients in view of their financial situation, needs and investment objectives.
There is no charge for an evaluation of your case. We handle our cases on a contingency fee basis. This means that unless we recover money for you, we charge no attorney’s fee.
If you incurred losses on your investment and would like your case evaluated by a securities attorney, please contact us.
Some of the information in this blog post was obtained from FINRA on 11/4/25. If you believe this information was reported incorrectly, please contact our firm: 1-800-500-4442.